Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of SLE patients

From: Dysfunctional interferon-α production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus

Characteristic SLE patients (n = 43)
Age (years; mean [range]) 35.0 (21 to 56)
Sex (n; males/females) 2/41
Disease duration (years; mean [range]) 8.5 (0.1 to 18)
SLEDAI (mean ± SD) 3.72 ± 3.84
   Active (n = 9)a 9.55 ± 4.50
   Inactive (n = 34) 2.17 ± 1.42
Cutaneous manifestation (n [%]) 26 (60.5)
Arthritis (n [%]) 27 (62.8)
Renal manifestation (n [%]) 9 (20.9)
Cytopenia (n [%]) 11 (25.6)
Serositis (n [%]) 8 (18.6)
Prednisolone (n [%]; mean dosage [mg/day]) 41 (95.3); 13.0
Hydroxychloroquine (n [%]) 34 (79.1)
Azathioprine (n [%]) 4 (9.3)
Cyclosporin (n [%]) 1 (2.3)
Mizoribine (n [%]) 4 (9.3)
Mycophenolate mofetil (n [%]) 3 (7.0)
  1. aSystemic Lupus Erythematosus Disease Activity Index above 4. SD, standard deviation; SLE, systemic lupus erythematosus.